The LYNDIBULIN brand, founded in 2007 (United States), from 4 sister brands and 2214 competing brands. The LYNDIBULIN brand is owned by Ziopharm Oncology, a company listed in New York. LYNDIBULIN belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Ziopharm Oncology
(LYNDIBULIN)
over 5 years*
USD 0.02